Internal Medicine, Infectious Disease · Southfield, MI
NPI
1013957893
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
22301 Foster Winter Dr, 2nd Floor
Southfield, MI, 48075
Phone (248) 552-0620
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,883
109 services
Medicare patients, 2024
41
Average age 73
Drug cost, 2024
$96K
682 prescriptions
Company payments, 2025
$5.09
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vilma Drelichman was code G0010 (administration of hepatitis b vaccine), 17 times for 11 patients. In total Vilma Drelichman billed 109 services in 13 codes, and Medicare paid $9,883.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0010 Administration of hepatitis b vaccine | Office | 17 | 11 | $32.71 | $556 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $32.71 | $360 |
By year: 2022 $42K for 359 services; 2023 $25K for 264 services; 2024 $9,883 for 109 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 21 | 16 | $8.00 | $168 |
Medicare prescription drug claims, 2024
In 2024, the drug Vilma Drelichman prescribed most often to Medicare patients was Typhim Vi (Typhoid Vi Polysacch Vaccine), with 100 prescriptions and refills. In total Vilma Drelichman wrote 682 Medicare prescriptions that cost $96K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Typhim Vi Typhoid Vi Polysacch Vaccine | 100 | 100 | 100 | $12K |
| Azithromycin Generic | 92 | 92 | 87 | $347 |
| Havrix Hepatitis A Virus Vaccine/Pf | 74 | 74 | 61 | $7,960 |
| Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl | 71 | 78 | 68 | $7,045 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 60 | 60 | 59 | $4,343 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 33 | 33 | 23 | $7,266 |
| Ipol Poliomyelitis Vaccine, Killed | 31 | 31 | 31 | $2,069 |
| Menquadfi Mening Vac A,c,y,w135,c-Tet/Pf | 31 | 31 | 31 | $5,762 |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 25 | 25 | 25 | $7,986 |
| Twinrix Hepatitis A And B Vaccine/Pf | 24 | 24 | Under 11 | $3,493 |
| Ixiaro Japanese Encephalitis Vacc/Pf | 24 | 24 | 13 | $7,620 |
| Doxycycline Hyclate Generic | 21 | 30 | Under 11 | $585 |
| Yf-Vax Yellow Fever Vaccine Live/Pf | 14 | 14 | 14 | $3,080 |
Brand drugs: 457 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vilma Drelichman $5.09 ($5.09 in general payments such as food, travel and fees) from 1 company. The largest payer was Dynavax Technologies Corporation with $5.09.
| Company | Payments | Amount |
|---|---|---|
| Dynavax Technologies Corporation DVAX | 1 | $5.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.